| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.46 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.32 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |